WHO WE ARE
Meet our team
In our team, each member brings something unique to the table, but we share a commitment to providing high-quality products and ultimately developing efficient and affordable immunotherapeutic drugs for patients in need. Learn more about us below.
Chief Executive Officer & Founder
Chryssa Zografou has extensive experience in the field of human translational neuroimmunology, with an emphasis on B cell immunology. She completed her postdoc in the Department of Neurology at Yale University School of Medicine, where she studied the B-cell receptor repertoire. She continued in the Department of Neuropathology, University Hospital Zurich, where she gained broader expertise in recombinant antibody technologies.
Kevin C. O'Connor
Associate Professor of Neurology & Founder
Kevin C. O’Connor is a tenured Associate Professor of Neurology and Immunobiology at Yale School of Medicine. He took his postdoctoral training in Immunology at Harvard Medical School where he was promoted to Assistant Professor. He defined the mechanisms by which B cells, and the antibodies they produce, cause tissue damage in myasthenia gravis with the aim of improving therapeutic approaches. His investigative interests are in human translational immunology and neurology.
Assistant Professor of Neurology & Founder
Panos Stathopoulos is an Assistant Professor of Neurology at the University of Athens and a Principal Investigator in Neuroimmunology at Aeginiteio Hospital of Athens, with expertise in multiple sclerosis. He specialized in Neuroimmunology, initially at the University of Athens and continued at Yale University, in the Department of Neuroimmunology under the guidance of Dr. Kevin C. O’Connor. Dr. Stathopoulos and Dr. O’Connor have published more than 10 research articles on the pathogenicity of autoantibodies in myasthenia gravis.
Principal Investigator in Developmental Neurobiology & Founder
Myrto Denaxa is a Principal Investigator in Developmental Neurobiology at BSRC “A. Fleming”. She completed her postdoctoral studies at the National Institute for Medical Research (London, UK) and subsequently worked as a research coordinator at the Francis Crick Institute, in the laboratory of Dr.V. Pachni, where she studied and developed model organisms for neurodevelopmental diseases. Her research focuses on the role of interneurons of the mammalian brain in the onset of neurodevelopmental and neuropsychiatric diseases, such as epilepsy, schizophrenia, and autism spectrum disorders (ASD), as well as neurodegenerative disorders (Alzheimer’s and Parkinson's).
Principal Investigator in Molecular Cognitive Biology & Founder
Efthymios Skoulakis is a Principal Investigator in Molecular Cognitive Biology and Director of the Institute of Basic Biomedical Research at BSRC “A. Fleming”. His postdoctoral studies focused on the molecular neurobiology of learning and memory at Cold Spring Harbor Laboratory (N.Y., USA) and Baylor College of Medicine (Texas, USA). In 1997 he was elected Assistant Professor of Biology at Texas A&M University (Texas, USA). His research focuses on the identification of neural mechanisms involved in the reception, evaluation, and transmission of stimuli important for the acquisition, storage, and recall of information and the investigation of changes in these mechanisms in congenital cognitive, psychiatric and neurodegenerative diseases.